TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›DDS
DDS logo

DDS

DILLARD'S, INC.

Next earnings Aug 10, 2026 · consensus $4.35 EPS, $1.54B rev

Last earnings +0.4% on 2026-05-14

Hold
$547.21
▲ +1.83%
$547.21▲ +37.67%
over 1Y
L $397.47H $699.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.8%
1W-5.9%
1M-7.7%
3M-4.4%
YTD-14.0%
1Y+37.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B-
Valuation
Overvalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 11 analysts
Sell

Cash-rich, real-estate-backed department store with 32% ROE, but earnings keep normalizing down from the post-COVID peak.

Diluted EPS $36.42 · FY2026

The read

Middling fundamentals and a rich price (~38% above fair value) leave little margin of safety — a wait-and-see.

Dillard's is an unusually well-managed and conservatively financed department-store operator whose earnings are normalizing after an extraordinary post-pandemic profit surge. FY2026 revenue was essentially flat at $6.47B (-0.1%), with net income of $570M (-3.9%) and diluted EPS of $36.42 (-1.1%) — the share-count reduction softening the earnings decline. The trend is the issue: net income has fallen from $892M (FY2023) to $570M as gross margin (39.5%, still healthy) and demand revert toward more typical department-store levels. Net margin of 8.8% remains strong for the format, and ROE of a remarkable 32.1% reflects both genuine profitability and an equity base shrunk by years of aggressive buybacks.

The balance sheet and cash generation are the real attraction. Dillard's carries modest debt, holds $861M cash (+20.0%), current assets ($2.39B) cover current liabilities ($902M) more than 2.6x, and operating cash flow was steady at $717M on just $93.4M of capex. That cash funds heavy capital return — a sharply higher dividend ($485M, +17.2%, including specials) plus $108M of buybacks. Crucially, the company owns much of its real estate, providing an asset-value backstop the 10.8x-ish earnings-yield headline understates.

Is DDS a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~547.21
  • Short call 575 @ ~30.56 est
debit $51,665max +$5,835max −$51,664BE 516.65

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$6.49B$6.87B$6.75B$6.48B$6.47B
Gross profit$2.75B$2.89B$2.72B$2.56B$2.56B
Operating income—————
Net income$862M$892M$739M$593M$570M
Diluted EPS$41.88$50.81$44.73$36.82$36.42
Net margin13.3%13.0%10.9%9.2%8.8%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.05B
EV / EBITDA—
EV / Sales1.2
EV / FCF12.9
P / FCF13.7
PEG (trailing)—
Earnings yield6.7%
FCF yield7.3%

Quality & risk

ROIC (est.)—
Free cash flow$624M
Total debt$366M
Net cash$496M
Piotroski F-Score5/9

Capital returns

Buyback yield1.3%
Dividend yield (est.)5.7%
Shareholder yield6.9%
Shares Δ YoY-2.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 10-Q Quarterly report2026-06-05
  2. 8-K Acquisition / disposition2026-06-04
  3. 8-K Shareholder vote2026-06-01
  4. 8-K Earnings results2026-05-14
  5. 10-K Annual report2026-03-27
  6. 8-K Material agreement2026-03-20
  7. 8-K Earnings results2026-02-24
  8. 10-Q Quarterly report2025-12-05
  9. 8-K Earnings results2025-11-13

Recent filings

all on EDGAR ↗
4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗4Period ending 2026-06-292026-06-30open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueA-
GrowthF
ProfitabilityA-
Financial healthA-
MomentumC
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$340.53

Overvalued -38% vs price

cheapfair valueexpensive

Modified Graham: EPS $36.42 × (8.5 + 1.5 × 0.0% growth) × 1.10 quality = 9.4× multiple. An estimate, not a price target.

407.3552-week699.51
Revenue
$6.47B
-0.1% YoY
Net margin
8.8%
ROE
32.1%
P/E
15.0

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$6.47B-0.1%
Net income$570M-3.9%
Gross profit$2.56B-0.2%
Diluted EPS$36.42-1.1%
Cash & equivalents$861M+20.0%
Total assets$3.51B-0.7%
Stockholders' equity$1.78B-1.0%
Gross: 39.5%

Frequently asked

Is DILLARD'S, INC. (DDS) a buy?
DDS currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cash-rich, real-estate-backed department store with 32% ROE, but earnings keep normalizing down from the post-COVID peak.
What is DDS's fair value?
A Modified-Graham model based on DDS's SEC fundamentals estimates a fair value of about $340.53. It is an estimate from reported earnings, not a price target.
Is DDS overvalued or undervalued?
Against a Modified-Graham fair-value estimate, DDS currently appears overvalued relative to its SEC-grounded earnings power.
What is DILLARD'S, INC.'s quality score?
DDS scores 67.67581512768702/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000028917, latest 10-Q filed 2026-06-05) · EODHD · Proprietary analysis · as of 6/21/2026, 8:51:56 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-29
DILLARD ALEX
PRESIDENT
Award23.00 @ $545.93$12.6K
2026-06-29
MATHENY DRUE
EXECUTIVE VICE PRESIDENT
Award16.00 @ $545.93$8.73K
2026-06-29
Mahaffy Denise Dillard
SENIOR VICE PRESIDENT
Award13.00 @ $545.93$7.10K
2026-06-29
STOCKMAN JAMES D
VICE PRESIDENT
Award16.00 @ $545.93$8.73K
2026-06-29
LITCHFORD MIKE
VICE PRESIDENT
Award18.00 @ $545.93$9.83K
2026-06-29
Watts Phillip R.
SENIOR VICE PRESIDENT
Award14.00 @ $545.93$7.64K
2026-06-29
Worley Dean L.
VP/GENERAL COUNSEL & SECRETARY
Award12.00 @ $545.93$6.55K
2026-06-29
Jazic Annemarie
VICE PRESIDENT
Award10.00 @ $545.93$5.46K

Held by tracked funds

Form 13F · SEC · quarterly
Renaissance Technologies142K sh$81.3M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Dividends

Quarterly
Yield (TTM)
5.7%
Annual / share
$31.20
Last ex-date
2026-06-30
Last amount
$0.30
ex 2026-06-30paid 2026-08-03$0.30
ex 2026-03-31paid 2026-05-04$0.30
ex 2025-12-31paid 2026-02-02$0.30
ex 2025-12-12paid 2026-01-05$30.00
ex 2025-09-30paid 2025-11-03$0.30
ex 2025-06-30paid 2025-08-04$0.25

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-14Beat +21.8% est▼ -4.80%8-K ↗
2026-02-24Beat +23.0% est▼ -10.03%8-K ↗
2025-11-13Beat +34.3% est▲ +4.71%8-K ↗
2025-08-14—▲ +6.67%8-K ↗
2025-05-15—▲ +2.64%8-K ↗
2025-02-25—▼ -19.36%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2015-06-07Thomas MacArthurSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score68 vs 67
Revenue growth-0.1% vs 7.5%
Net margin8.8% vs 10.0%
Return on equity32.1% vs 12.0%
P/E15.0 vs 26.2